ACTU

Actuate Therapeutics Inc$1.71-0.02 (-1.16%)

Prev Close$1.73·MCap$68.5M·P/E—·Vol257.4K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$2.15M

◆

Net Activity

Net Seller

$2.15M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Actuate Therapeutics Inc (ACTU) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $2.15M. The most recent insider transaction was by SCHMITT DANIEL M (President, CEO and Director), who sold $527.7K worth of shares on Feb 13, 2026. Actuate Therapeutics Inc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $68.5M.

ACTU Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Feb 13, 2026	SCHMITT DANIEL M	President, CEO and Director	Sell	121,874	$4.33	$527.7K0.5% OS
Jan 5, 2026	THOMSON TODD S	Director	Sell	280,000	$5.80	$1.62M1.2% OS
Jun 27, 2025	Kreis Leslie W.	Director	Buy	71,428	$7.00	$500.0K
Aug 12, 2024	Fletcher Aaron G.L.	Director	Buy	500,000	$8.00	$4.00M2.1% OS
Aug 12, 2024	Fletcher Aaron G.L.	Director	Sell	62,950	$6.75	$425.0K
Aug 12, 2024	THOMSON TODD S	Director	Sell	47,214	$6.35	$300.0K

ACTU Insider Buying Activity

The following table shows recent insider purchases of Actuate Therapeutics Inc (ACTU) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 27, 2025	Kreis Leslie W.	Director	Buy	71,428	$7.00	$500.0K	0
Aug 12, 2024	Fletcher Aaron G.L.	Director	Buy	500,000	$8.00	$4.00M2.1% OS	0

ACTU Insider Selling Activity

The following table shows recent insider sales of Actuate Therapeutics Inc (ACTU) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Feb 13, 2026	SCHMITT DANIEL M	President, CEO and Director	Sell	121,874	$4.33	$527.7K0.5% OS
Jan 5, 2026	THOMSON TODD S	Director	Sell	280,000	$5.80	$1.62M1.2% OS
Aug 12, 2024	Fletcher Aaron G.L.	Director	Sell	62,950	$6.75	$425.0K
Aug 12, 2024	THOMSON TODD S	Director	Sell	47,214	$6.35	$300.0K